Abstract
Hospitalized patients receiving anticoagulants such as warfarin are at increased risk for adverse events because of difficulties maintaining a therapeutic international normalized ratio (INR). We sought to determine whether a detailed warfarin dosing protocol administered by pharmacists with minimal physician oversight significantly reduced the proportion of hospitalized patients with a supratherapeutic INR. We conducted a prospective, nonrandomized trial with patients on cardiology, internal medicine, and family medicine inpatient services who received at least 1 dose of warfarin while hospitalized. The baseline group included 293 patients, and the intervention group comprised 217 patients. Baseline characteristics were similar in each group, except that more patients received antibiotics in the intervention group. The defect rate (INR > 5 after receiving warfarin) in the baseline group was significantly higher than in the intervention group (7.85 vs. 1.85%). Conversely, the percentage of patients with an INR less than 1.7 after 4 warfarin doses was lower in the intervention patients, indicating overall improvement in therapeutic levels. Dosing discussions were required between the pharmacist and a physician for only 6% of intervention patients. The protocol effectively reduced overanticoagulation without increasing under anticoagulation during hospitalization and reduced the need for close physician oversight.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- INR:
-
International normalized ratio
- LOS:
-
Length of stay
References
Hirsh J, Guyatt G, Albers GW, Harrington R, Schunemann HJ, American College of Chest Physicians (2008) Executive summary: American college of chest physicians evidence-based clinical practice guidelines 8th edn. Chest 133(6):71S–109S. Erratum in: Chest 2008; 134(4):892
van Walraven C, Austin PC, Oake N, Wells P, Mamdani M, Forster AJ (2007) The effect of hospitalization on oral anticoagulation control: a population-based study. Thromb Res 119(6):705–714
Dawson NL, Klipa D, O’Brien AK, Crook JE, Cucchi MW, Valentino AK (2011) Oral anticoagulation in the hospital: analysis of patients at risk. J Thromb Thrombolysis 31(1):22–26
Jacobs LG (2006) Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly. Clin Geriatr Med 22(1):17–32 Vii–viii
The Joint Commission: helping health care organizations help patients (Internet). Oakbrook Terrace (IL): The Joint Commission; c2010. National patient safety goals: 2010 national patient safety goals (NPSGs): effective July 1, 2010 (cited 2010 Aug 25). Available from http://www.jointcommission.org/PatientSafety/NationalPatientSafetyGoals/
Gouin-Thibault I, Levy C, Pautas E, Cambus JP, Drouet L, Mahe I et al (2010) Improving anticoagulation control in hospitalized elderly patients on warfarin. J Am Geriatr Soc 58(2):242–247
Harrison L, Johnston M, Massicotte MP, Crowther M, Moffat K, Hirsh J (1997) Comparison of 5–mg and 10–mg loading doses in initiation of warfarin therapy. Ann Intern Med 126(2):133–136
Eckhoff CD, Didomenico RJ, Shapiro NL (2004) Initiating warfarin therapy: 5 mg versus 10 mg. Ann Pharmacother 38(12):2115–2121
Crowther MA, Ginsberg JB, Kearon C, Harrison L, Johnson J, Massicotte MP et al (1999) A randomized trial comparing 5–mg and 10–mg warfarin loading doses. Arch Intern Med 159(1):46–48
Chai SJ, Macik BG (2002) Improving the safety profile of warfarin. Semin Hematol 39(3):179–186
Bond CA, Raehl CL (2004) Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, medicare charges, bleeding complications, and transfusions. Pharmacotherapy 24(8):953–963
Damaske DL, Baird RW (2005) Development and implementation of a pharmacist-managed inpatient warfarin protocol. Proc (Bayl Univ Med Cent) 18(4):397–400
Biscup-Horn PJ, Streiff MB, Ulbrich TR, Nesbit TW, Shermock KM (2008) Impact of an inpatient anticoagulation management service on clinical outcomes. Ann Pharmacother 42(6):777–782
Newall F, Monagle P, Johnston L (2005) Patient understanding of warfarin therapy: a review of education strategies. Hematology 10(6):437–442
Phillips KW, Wittkowsky AK (2007) Survey of pharmacist-managed inpatient anticoagulation services. Am J Health Syst Pharm 64(21):2275–2278
Donovan JL, Drake JA, Whittaker P, Tran MT (2006) Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance. J Thromb Thrombolysis 22(1):23–30
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
Target INR 2.0–3.0 (Table 3)
Target INR 2.5–3.5 (Table 4)
Pharmacist will use the following protocol for Continuation of Warfarin Therapy
Target INR 2.0–3.0 (Table 5)
Target INR 2.5–3.5 (Table 6)
This appendix is copyrighted by Mayo Foundation for Medical Education and Research, used with permission.
Rights and permissions
About this article
Cite this article
Dawson, N.L., Porter, I.E., Klipa, D. et al. Inpatient warfarin management: pharmacist management using a detailed dosing protocol. J Thromb Thrombolysis 33, 178–184 (2012). https://doi.org/10.1007/s11239-011-0655-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-011-0655-9